Treatment of Phlebitis
For superficial non-occlusive lower extremity phlebitis that is at least 5 cm in length, prophylactic anticoagulation with fondaparinux 2.5 mg daily or rivaroxaban 10 mg daily for 45 days is the recommended first-line treatment. 1, 2
Diagnosis and Assessment
- Ultrasound imaging is essential to confirm phlebitis diagnosis and exclude concurrent deep vein thrombosis (DVT), as approximately 25% of patients with superficial thrombophlebitis have underlying DVT 1, 2
- Comprehensive evaluation should assess the extent of thrombosis and proximity to the deep venous system 2
Treatment Based on Location and Severity
Extensive Lower Extremity Phlebitis (≥5 cm in length)
- First-line: Fondaparinux 2.5 mg subcutaneously once daily for 45 days 1, 2, 3
- Alternative: Rivaroxaban 10 mg orally daily for 45 days 1, 2
- Another alternative: Prophylactic-dose low molecular weight heparin (LMWH) for 45 days 1, 2, 3
- Anticoagulation reduces risk of progression to DVT (from 1.3% to 0.2%) and recurrent superficial vein thrombosis (from 1.6% to 0.3%) 1, 3
Phlebitis Near Saphenofemoral Junction
- If phlebitis is within 3 cm of the saphenofemoral junction, therapeutic dose anticoagulation for at least 3 months is recommended 1
Limited Phlebitis (<5 cm in length or below the knee)
- Consider repeat ultrasound in 7-10 days to assess for progression 1
- Consider anticoagulation if progression is found 1
Upper Extremity Phlebitis
- First-line treatment includes symptomatic measures (see below) 2
- Consider prophylactic anticoagulation only if there is symptomatic progression, progression on imaging, or if the clot is within 3 cm of the deep venous system 2
Symptomatic Treatment (for all types of phlebitis)
- Warm compresses to reduce inflammation and pain 1, 2, 4
- Non-steroidal anti-inflammatory drugs (NSAIDs) for pain control 1, 2, 4
- Elevation of the affected limb to reduce swelling 1, 2, 4
- Maintain mobility and avoid bed rest unless pain is severe 4
- Elastic compression (bandages or stockings) until elimination of the responsible varicose vein 4, 5
Catheter-Related Phlebitis
- If phlebitis is associated with a peripheral catheter that is no longer needed, remove the catheter 1, 2
- For prevention, intravenous catheters should be changed every 24-48 hours depending on venous flow and clinical parameters 4
- Topical nitroglycerin has shown effectiveness in reducing the inflammatory process in catheter-related phlebitis 6
Special Considerations
Cancer Patients
- Follow the same anticoagulation recommendations as non-cancer patients 1
- Closer monitoring is warranted due to higher risk of progression 2
Pregnant Patients
- LMWH is recommended over fondaparinux as fondaparinux crosses the placenta 1, 3
- Treatment should continue for the remainder of pregnancy and 6 weeks postpartum 3
Septic Phlebitis
- Prompt removal of any intravenous device 7
- Appropriate antibiotics based on culture results (most commonly targeting Staphylococcus aureus or Group A streptococcus) 7
- Consider surgical excision of the involved vein if clinical deterioration occurs or if septicemia persists after 24 hours despite conservative therapy 7
Monitoring and Follow-up
- Monitor for extension into the deep venous system, which would necessitate full therapeutic anticoagulation 1, 2
- For limited phlebitis being managed conservatively, repeat ultrasound in 7-10 days to assess for progression 1